Assembly Biosciences Inc. (ASMB)
Market Closed
27 Jul, 20:00
$
25. 91
+0.36
+1.409%
$
411.79M Market Cap
- P/E Ratio
- Div Yield
77,698 Volume
-1.19 Eps
$ 25.55
Previous Close 
Want to track ASMB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Assembly Biosciences Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| ADD Andrew D. Dickinson GILEAD SCIENCES Inc. | 4.51M | $93.64M | $116.27M | $22.63M | 24.17% |
 Farallon Capital Farallon Capital Management LLC | 1.23M | $31.43M | $31.68M | $254,233.89 | 0.81% |
 Point72 Asset Management LP Point72 Asset Management LP | 344,105 | $11.37M | $8.62M | -$2.75M | -24.16% |
 David Kim Paradigm Biocapital Advisors LP | 665,251 | $22.63M | $17.16M | -$5.46M | -24.14% |
 Kevin Roan Stempoint Capita LLP | 185,435 | $5.57M | $4.75M | -$818,456.85 | -14.69% |
| AA Andrew Alkon EntryPoint Capital, LLC | 12,384 | $343,656 | $319,507.2 | -$24,148.8 | -7.03% |
| BGI B Group Inc. B Group Inc. | 175,706 | $1.84M | $4.6M | $2.76M | 149.64% |
